Logo XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. fluid analysis
Show results for
Products
Services
Software
Training
Applications

Companies

News
Articles
Books
Magazines
Downloads
Videos

Refine by
Date

  • Older

Fluid Analysis Articles & Analysis

80 news found

Microneedle Market Projected to Reach $1.3 Billion by 2028, Reveals Latest BCC Research Study

Microneedle Market Projected to Reach $1.3 Billion by 2028, Reveals Latest BCC Research Study

Boston: Microneedle technology, driven by high demand in dermatologic procedures and its versatile applications in drug delivery, vaccine administration, and disease diagnostics, faces challenges in its complex manufacturing process. Ongoing research and numerous products in development make this market dynamic for newcomers entering the field. “According to the latest BCC Research study, ...

ByBCC Research


Daxor Corporation Announces Significant Expansion With Five Hospitals Implementing Its BVA-100 Blood Volume Diagnostic for Heart Failure Patients

Daxor Corporation Announces Significant Expansion With Five Hospitals Implementing Its BVA-100 Blood Volume Diagnostic for Heart Failure Patients

Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces five new hospitals have implemented the Company’s BVA-100 blood volume diagnostic for clinical use to guide fluid management in heart failure patients during the first quarter of 2023. The addition of these hospitals contributes to the significant growth of blood ...

ByDaxor Corporation


Pilot Randomized Controlled Trial Validates Daxor BVA-100 Diagnostic for Heart Failure Patients

Pilot Randomized Controlled Trial Validates Daxor BVA-100 Diagnostic for Heart Failure Patients

Data were presented as a moderated featured abstract at the Technology Heart Failure Therapeutics Conference, which focuses on device and technology-based treatments in heart failure, held March 20-22, 2023 in Boston, Mass. Blood volume analysis (BVA) was used in hospitalized heart failure patients to study the effects of BVA-guided care on decongestion therapy and outcomes ...

ByDaxor Corporation


New Study Confirms Daxor’s BVA-100 Volume Metric Compared to CardioMEMS Pressure Metric Has Unique Clinical Utility as a Diagnostic for Heart Failure Patients

New Study Confirms Daxor’s BVA-100 Volume Metric Compared to CardioMEMS Pressure Metric Has Unique Clinical Utility as a Diagnostic for Heart Failure Patients

The study, titled “Persistent Pressure-Volume Dissociation During CardioMEMS Monitoring,” compared volume and pressure in heart failure (HF) patients who underwent CardioMEMS implantation to measure pressure, and direct measurement of total blood volume using Daxor’s blood volume analysis (BVA) diagnostic. Veraprapas Kittipibul M.D., lead investigator of the ...

ByDaxor Corporation


Daxor Corporation Appoints Linda Cooper, Vice President Project Management

Daxor Corporation Appoints Linda Cooper, Vice President Project Management

Daxor’s mission is to advance healthcare by enabling optimal fluid management with blood volume analysis. Daxor’s vision is optimal blood volume for ...

ByDaxor Corporation


Daxor Corporation Joins the Heart Failure Society of America (HFSA) as a Corporate Member

Daxor Corporation Joins the Heart Failure Society of America (HFSA) as a Corporate Member

Daxor’s mission is to advance healthcare by enabling optimal fluid management with blood volume analysis. Daxor’s vision is optimal blood volume for ...

ByDaxor Corporation


Newly Published Study Proves Value and CliNewly Published Study Proves Value and Clinical Benefit of Daxor’s Blood Volume (BVA-100) Diagnostic in the Evaluationnical Benefit of Daxor’s Blood Volume (BVA-100) Diagnostic in the Evaluation of Heart Failure

Newly Published Study Proves Value and CliNewly Published Study Proves Value and Clinical Benefit of Daxor’s Blood Volume (BVA-100) Diagnostic in the Evaluationnical Benefit of Daxor’s Blood Volume (BVA-100) Diagnostic in the Evaluation of Heart Failure

” “More than 135 published peer-reviewed studies, and over a dozen this past year alone, have proven that blood volume analysis informs clinicians with critical information to manage and treat volume derangements in heart failure and many other medical conditions,” said Michael Feldschuh, President, and CEO of Daxor Corporation. “This study adds further ...

ByDaxor Corporation


Daxor Corporation Announces Closing of $2.1 million Underwritten Public Offering and Exercise of Over-Allotment Option

Daxor Corporation Announces Closing of $2.1 million Underwritten Public Offering and Exercise of Over-Allotment Option

Daxor’s mission is to advance healthcare by enabling optimal fluid management with blood volume analysis. Daxor’s vision is optimal blood volume for ...

ByDaxor Corporation


Daxor Corporation Announces Pricing of $2.0 million Underwritten Public Offering

Daxor Corporation Announces Pricing of $2.0 million Underwritten Public Offering

Daxor’s mission is to advance healthcare by enabling optimal fluid management with blood volume analysis. Daxor’s vision is optimal blood volume for ...

ByDaxor Corporation


Daxor Corporation Announces Launch of Proposed Underwritten Public Offering

Daxor Corporation Announces Launch of Proposed Underwritten Public Offering

Daxor’s mission is to advance healthcare by enabling optimal fluid management with blood volume analysis. Daxor’s vision is optimal blood volume for ...

ByDaxor Corporation


Live Webinar by MedAxiom Features Best Practices Using Daxor’s Blood Volume Analysis (BVA-100) to Improve Heart Failure Outcomes & Reduce Costs

Live Webinar by MedAxiom Features Best Practices Using Daxor’s Blood Volume Analysis (BVA-100) to Improve Heart Failure Outcomes & Reduce Costs

Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces Daxor’s BVA-100 diagnostic will be featured in a MedAxiom Academy webinar – Best Practices for Using Blood Volume Analysis to Reduce Heart Failure LOS, Readmissions, Mortality and Costs on November 17, 2022, at 1pm ET. ...

ByDaxor Corporation


Newly Published Study Demonstrates Significant Clinical Utility of Daxor’s Blood Volume (BVA-100) Diagnostic in the Evaluation of Heart Failure

Newly Published Study Demonstrates Significant Clinical Utility of Daxor’s Blood Volume (BVA-100) Diagnostic in the Evaluation of Heart Failure

” The study titled, “Blood Volume Analysis and Hemodynamic Measures of Vascular Compliance in Patients with Worsening Heart Failure,” assessed the relationship between blood volume, resting, and stress cardiovascular pressures in worsening HF. Patients presenting to the hospital or outpatient clinic with clinical worsening HF underwent blood volume ...

ByDaxor Corporation


Daxor Corporation to Exhibit at American Heart Association’s Scientific Sessions 2022

Daxor Corporation to Exhibit at American Heart Association’s Scientific Sessions 2022

Daxor’s mission is to advance healthcare by enabling optimal fluid management with blood volume analysis. Daxor’s vision is optimal blood volume for ...

ByDaxor Corporation


Daxor Corporation to Exhibit & Present at the Medaxiom Cardiovascular Transforum Conference Fall’22 to Advance Awareness & Further Adoption of Daxor’s Blood Volume Diagnostic (BVA-100)

Daxor Corporation to Exhibit & Present at the Medaxiom Cardiovascular Transforum Conference Fall’22 to Advance Awareness & Further Adoption of Daxor’s Blood Volume Diagnostic (BVA-100)

Daxor recently announced in July that it has entered an industry partnership with MedAxiom, an American College of Cardiology company, to amplify awareness and adoption of Daxor’s blood volume analysis (BVA) technology among MedAxiom’s clinical members. “We are delighted to attend CV Transforum for the first time, bringing Daxor’s innovative BVA ...

ByDaxor Corporation


Expert Panel Calls for Use of Blood Volume Measurement to Assess Heart Failure Patients at Key Scientific Meeting

Expert Panel Calls for Use of Blood Volume Measurement to Assess Heart Failure Patients at Key Scientific Meeting

Miller also highlighted the importance of knowing the red blood cell volume to optimize fluid management which is a key metric of Daxor’s BVA-100 blood test, which he has utilized to publish more than a dozen peer-reviewed papers in leading journals. ...

ByDaxor Corporation


Study Data from Mayo Clinic on Heart Failure Treatment Effectiveness Utilizing Daxor BVA-100 Presented at Key Scientific Meeting

Study Data from Mayo Clinic on Heart Failure Treatment Effectiveness Utilizing Daxor BVA-100 Presented at Key Scientific Meeting

This study adds to the considerable evidence that shows why blood volume analysis is urgently needed as it is the most sensitive and specific diagnostic tool for volume measurement in heart failure with significant outcome and cost improvements associated for patient care when used to guide ...

ByDaxor Corporation


New Data Shows 85% Reduction in One-Year Mortality for Medicare Heart Failure Patients With BVA-Guided Care

New Data Shows 85% Reduction in One-Year Mortality for Medicare Heart Failure Patients With BVA-Guided Care

Daxor’s mission is to advance healthcare by enabling optimal fluid management with blood volume analysis. Daxor’s vision is optimal blood volume for ...

ByDaxor Corporation


New Studies Validating the Uniqueness of the BVA-100 Blood Test for Heart Failure Patients Compared to Pressure Measures

New Studies Validating the Uniqueness of the BVA-100 Blood Test for Heart Failure Patients Compared to Pressure Measures

“Correlation Between Pressure and Volume in Ambulatory Heart Failure: Sex-Specific Analysis”: Differences in cardiac structure and physiology exist between women and men with HF. ...

ByDaxor Corporation


New Data Shows Heart Failure Treatment Guided by Daxor’s BVA-100 Lowers Hospital Length of Stay by 55%

New Data Shows Heart Failure Treatment Guided by Daxor’s BVA-100 Lowers Hospital Length of Stay by 55%

” The study titled “Length of Stay After Blood Volume Analysis in Hospitalized Heart Failure” compared both hospital admission and discharge dates, allowing the calculation of pre- and post-BVA LOS for all patients. ...

ByDaxor Corporation


Military-approved portable oil analysis lab now available for commercial sale

Military-approved portable oil analysis lab now available for commercial sale

Chelmsford, Massachusetts, October 2022 – AMETEK Spectro Scientific, one of the world’s largest suppliers of oil and fuel analysis instrumentation and software, has released a unique portable oil analysis laboratory that has delivered proven operational benefits for the US Military. ...

ByAMETEK Spectro Scientific

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About XPRT Media

XPRT is a global industry marketplace and information resource. Online product catalogs, news, articles, events, publications & more.


  • FAQs
  • Company sitemap
  • Category sitemap
XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
Medical XPRT